CAPTRUST Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264K | Sell |
15,738
-998
| -6% | -$16.7K | ﹤0.01% | 2132 |
|
|
2025
Q1 | $257K | Buy |
16,736
+8,457
| +102% | +$130K | ﹤0.01% | 2025 |
|
|
2024
Q4 | $182K | Sell |
8,279
-7,507
| -48% | -$165K | ﹤0.01% | 2153 |
|
|
2024
Q3 | $284K | Buy |
15,786
+5,146
| +48% | +$92.7K | ﹤0.01% | 1907 |
|
|
2024
Q2 | $173K | Buy |
+10,640
| New | +$173K | ﹤0.01% | 2068 |
|
|
2024
Q1 | – | Sell |
-13,171
| Closed | -$138K | – | 2622 |
|
|
2023
Q4 | $138K | Buy |
13,171
+387
| +3% | +$4.04K | ﹤0.01% | 2481 |
|
|
2023
Q3 | $130K | Buy |
+12,784
| New | +$130K | ﹤0.01% | 2397 |
|
|
2022
Q3 | – | Sell |
-2,727
| Closed | -$21K | – | 3852 |
|
|
2022
Q2 | $21K | Sell |
2,727
-2,461
| -47% | -$19K | ﹤0.01% | 3351 |
|
|
2022
Q1 | $49K | Sell |
5,188
-1,289
| -20% | -$12.2K | ﹤0.01% | 2794 |
|
|
2021
Q4 | $52K | Buy |
6,477
+4,995
| +337% | +$40.1K | ﹤0.01% | 2638 |
|
|
2021
Q3 | $14K | Hold |
1,482
| – | – | ﹤0.01% | 3411 |
|
|
2021
Q2 | $15K | Hold |
1,482
| – | – | ﹤0.01% | 3319 |
|
|
2021
Q1 | $17K | Sell |
1,482
-357
| -19% | -$4.1K | ﹤0.01% | 3120 |
|
|
2020
Q4 | $18K | Buy |
1,839
+709
| +63% | +$6.94K | ﹤0.01% | 2303 |
|
|
2020
Q3 | $10K | Buy |
1,130
+589
| +109% | +$5.21K | ﹤0.01% | 2287 |
|
|
2020
Q2 | $6K | Buy |
+541
| New | +$6K | ﹤0.01% | 2361 |
|